Skip to main content

Table 6 Bacterial culture results, complications, and treatment of 83 deaths with COVID-19 pneumonia after admission

From: Clinical characteristics of a group of deaths with COVID-19 pneumonia in Wuhan, China: a retrospective case series

  Patients, n(%)
Bacterial culture results 36(43.4%)
 Sputum bacteria culture positive 22(26.5%)
 Blood bacteria culture positive 9(10.8%)
 Urine bacteria culture positive 5(6.2%)
 Fecal bacteria culture positive 0
Complications
 Acute respiratory failure 71(85.5%)
 Acute myocardial infarction 6(7.2%)
 Heart failure 37(44.6%)
 Acute liver injury 9(10.8%)
 Acute kidney injury 22(26.5%)
 Gastrointestinal bleeding 16(19.2%)
 Sepsis 69(83.1%)
 Shock 33(39.8%)
Treatments
 Antiviral therapy 83(100%)
  Monotherapy
   Abidole 6(7.2%)
  Combination therapyAbidole
   Abidole/ Oseltamivir 57(68.7%)
   Abidole/ Ribavirin 16(19.3%)
   Abidole/ Lopinavir and Ritonavir 3(3.6%)
   Abidole/ Oseltamivir/ Lopinavir and Ritonavir 1(1.2%%)
 Antifungal therapy 2(2.4%%)
 Antibiotic therapy 81(97.6%)
  Penicillins 24(28.9%)
  Cephalosporins 52(62.7%)
  Quinolone 35(42.2%)
  Vancomycin 11(13.3%)
 Glucocorticoid therapy 54(65.1%)
 Intravenous immunoglobulin therapy 39(47.0%)
 CRRT 6(7.3%)
 Invasive mechanical ventilation 20(24.1%)
 Non-invasive mechanical ventilation 51(61.4%)
 High flow nasal cannula 12(14.5%)
 ECMO 1(1.2%)
  1. CRRT continuous renal replacement therapy, ECMO extracorporeal membrane oxygenation